|
|
|
|
|
| |
Current
Issues - Newsletter
May-June 2006 |
|
| |
|
|
|
|
|
| |
Sabinsa Corporation
Opens Office in Germany
|
|
| |
| |
|
Sabinsa Europe GmbH, in Langen,
Germany commenced operations last
month. Lutz Weise, Ph.D., has been
appointed resident director of Sabinsa
Europe GmbH and Simone Rexin has
been hired as business development
manager. Dr. Weise has a doctorate in
chemical engineering, as well as an
MBA. He is fluent in French, German
and English, and has extensive scientific
marketing experience in the
biotechnical and pharmaceutical
industries. Rexin holds an MBA and is
an experienced sales and marketing
manager with extensive expertise in
the cosmetic and food industries. She
is also fluent in German, English,
French, Spanish and Italian.
Kavita Subramanian, senior manager
of international business development
at Sabinsa's headquarters in New
Jersey, will continue to serve as the corporate
liaison for the European
division.
|
|
|
|
|
|
|
| |
New Clinical Study with Selenium SeLECT |
|
| |
| |
Arecent clinical study in the United
States on selenium replete subjects
further established the bioavailability
and safety of Selenium SeLECT.
Subjects were grouped to receive
either selenomethionine, high- selenium
yeast or sodium selenite in moderate
to high doses. The effect on
urinary excretion of selenium biomarkers
was measured by after 16
weeks of supplementation. "Effects
of Chemical Form of Selenium on
Plasma Biomarkers in a High-Dose
Human Supplementation Trial" published
in the April 2006 edition of
Cancer Epidemiology, Biomarkers &
Prevention, a journal distributed by
the American Association for Cancer
Research, found that bioavailability of
selenium was greatest for selenomethionine
(as Selenium SeLECT from
Sabinsa Corporation), less for highselenium
yeast and the least for sodium
selenite.
As summarized by Vladimir
Badmaev, M.D., Ph.D., vice president
of scientific and medical affairs,
Sabinsa Corporation: "This study further
substantiates the fact that selenium
in the form of selenomethionine,
specifically our Selenium SeLECT
compound, is more available to be
absorbed and used by the body.
Additionally, some of the participants
had total daily intakes of more than
800 micrograms of selenium over the
course of the study and showed no
signs of selenium toxicity despite the
fact that 800 micrograms is well
above the recognized safe upper limit
set by the Institute of Medicine." |
|
|
|
|
|
| |
Dr. Majeed Speaks on Ayurveda
|
|
| |
| |
 |
Dr. Muhammed Majeed, founder
and CEO of Sabinsa Corporation,
spoke to an international audience at
the Indian Expo, an exhibition organized
by India’s department of AYUSH
(Ayurveda, Yoga and Naturopathy,
Unani, Siddha and Homeopathy)
which was held in conjunction with
the World Health Organization's
annual World Health Assembly. Dr.
Majeed discussed the origins of
Ayurveda and Ayurveda in the context
of western medical science. He highlighted
clinical research surrounding
several herbs traditionally used in
Ayurvedic medicine as part of the
inaugural day of the exhibition held
May 24 - 26, 2006, at the Hotel Intercontinental
in Geneva, Switzerland. |
|
|
|
|
|
|
| |
Successful Debut of
Sabinsa on Wheels |
|
| |
| |
Sabinsa Corporation successfully
kicked off its "Sabinsa on Wheels"
tour in Miami, Florida on April 20th
2006 Sabinsa on Wheels is a series of
one-day seminars being conducted in
select U.S. cities to provide nutraceucorporate
tical and cosmeceutical industry
members with the latest information
on the company's ingredient research
and development in categories including
prevention, performance, wellness,
beauty inside and out, nature and
nurture. Other tour sites include
Salt Lake City, Utah, on June 20, 2006,
and Los Angeles, California, on June
22, 2006.
|
Dr. Aggarwal presenting
a paper at the
Sabinsa on Wheels in Florida |
Dr. N. Kalyanam presents ‘ Seleium’ |
|
|
|
|
|
|
| |
Cosmetics Corner |
|
| |
| |
| Sabinsa Corporation exhibited at
the NYSCC Supplier's Day at NJ
Expo Center on May 16 and 17. |
 |
Two new botanical extracts for use
in sun care, after-sun care and "antiaging"
formulations, were added to
the product line.
Rosemary T3 Complex™ is an
enriched “Triterpenoid Rosemary
Extract” containing Ursolic acid,
Betulinic acid and Oleanolic acid, in a
standardized proprietary composition.
Laboratory studies showed that this
combination of triterpenoids has a significantly
higher antioxidant property
as compared to the pure actives.
Recommended use levels in creams
and lotions is 0.1-0.5 % w/w.
|
| Gallnut extract is a polyphenol rich
extract derived from the galls of the
Quercus infectoria tree. In vitro
studies show that this natural extract
is an efficacious antioxidant and an
efficient inhibitor of collagenase and
hyaluronidase, enzymes that catalyze
the break down of connective
tissues. The extract would therefore potentially help in maintaining
healthy skin texture and tone.
Recommended use levels in creams
and lotions is 0.05 to 0.3% |
|
|
|
|
|
|
| |
Product Ads |
|
| |
| |
Look for new product advertisements
in the following publications:
|
| |
- Chemical Market Reporter
- Cosmetics & Toiletries, HAPPI
- Soap Perfumery & Cosmetics,
- Natural Products Insider
- Nutritional OutLook
- Functional Foods and
- Nutraceuticals
|
|
|
|
|
|
| |
Sabinsa Shows |
|
| |
| |
ChemSpec Europe (Fine Chemicals)
June 14-15 Geneva, Switzland
NNFA Natural Marketplace
July 15-17 Las Vegas, NV
|
| |
- Chemical Market Reporter
- Cosmetics & Toiletries, HAPPI
- Soap Perfumery & Cosmetics,
- Natural Products Insider
- Nutritional OutLook
- Functional Foods and
- Nutraceuticals
|
|
|
|
|
|
| |
Products |
|
| |
|
|
| |
|
|
| |
The products offered by
Sabinsa Corporation are
 |
|
| |
|
|
| |
"The information
presented in the "Current Issues" Newsletter
from Sabinsa Corporation is for informational purposes
only. It is abstracted from web and print media
sources. Readers are advised to refer to the original
sources for additional information".
|
|
|
|
| |
|
|
|
